Purpura, Thrombocytopenic, Idiopathic
Showing 1 - 25 of 3,370
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Immune Thrombocytopenia Trial (VIT D)
Not yet recruiting
- Immune Thrombocytopenia
- VIT D
- (no location specified)
Oct 5, 2023
Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)
Completed
- Idiopathic Thrombocytopenic Purpura
- Placebo
- AMG 531
- (no location specified)
Nov 4, 2022
Immune Thrombocytopenic Purpura Trial in Sohag (serum interleukin 10 level)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- serum interleukin 10 level
-
Sohag, EgyptSohag University Hospital
Apr 18, 2023
Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)
Completed
- Idiopathic Thrombocytopenic Purpura
- +2 more
- Romiplostim
- (no location specified)
Nov 10, 2022
Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)
Active, not recruiting
- Idiopathic Thrombocytopenic Purpura
- R788
- Placebo
-
Multiple Locations, JapanResearch Site
Mar 22, 2022
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
COVID-19 Vaccine and Development of Immune Thrombocytopenic
Recruiting
- COVID-19 Vaccine
- covid19 vaccines
-
Assiut, EgyptEgypt
Jul 12, 2022
Caplacizumab-treated Pediatric Immune-mediated Thrombocytopenic
Active, not recruiting
- Immune-mediated Thrombocytopenic Purpura
-
Chilly-Mazarin, FranceSanofi-Aventis
Aug 8, 2022
Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- Genotyping of rs1883832C/T related single-nucleotide polymorphism
-
Sohag, EgyptSohag University hospitals
Oct 16, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022
Idiopathic Thrombocytopenic Purpura Trial in Wuhan, Chengdu, Tianjin (Hetrombopag Olamine, matching )
Completed
- Idiopathic Thrombocytopenic Purpura
- Hetrombopag Olamine
- matching placebo
-
Wuhan, Hubei, China
- +2 more
Aug 2, 2022
Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)
Not yet recruiting
- Immune Thrombocytopenia
- peripheral blood and bone marrow withdrawal
- (no location specified)
Jan 12, 2023
Immune Thrombocytopenia Trial in Hong Kong (Eltrombopag)
Suspended
- Immune Thrombocytopenia
-
Hong Kong, Hong Kong SAR, Hong KongHumanity & Health Research Centre
Mar 16, 2022
Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)
Enrolling by invitation
- Refractory Systemic Lupus Erythematosus
- +2 more
- CNCT19 cell injection
-
Peking, ChinaXiaofeng Zeng
Jul 3, 2023
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Platelets Sialylation by Flow Cytometry for Differential
Completed
- Idiopathic Thrombocytopenic Purpura
- non interventional study
-
Nantes, FranceNantes University Hospital
Jan 17, 2022
Some Cytokines Expression in ITP Primary Immune Thrombocytopenic
Recruiting
- Primary Immune Thrombocytopenia
- Plasma RNA isolation, qPCR analysis of micro RNA
- +2 more
-
Sohag, EgyptSohag University
May 7, 2022
Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)
Not yet recruiting
- Purpura, Thrombocytopenic, Idiopathic
- all-trans retinoic acid
- Eltrombopag
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jun 25, 2022
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Activity and Safety of Fostamatinib in Consecutive Adult ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- +2 more
- (no location specified)
Jan 12, 2023